| Characteristics | CIRD | p-value | |
| Present | Absent | ||
| Age (mean ± SD), years | 44.4 ± 15.2 | 44.2 ± 15.5 | 0.82 |
| Sex |
|
|
|
| -Females N (%) | 39 (78) | 39 (76.5) | 0.88 |
| -Males N (%) | 11 (22) | 12 (23.5) |
|
| Duration* (mean ± SD), years | 9 ± 7.6 | N/A |
|
| CIRD, N (%) |
| N/A |
|
| -Rheumatoid arthritis | 50 (45.9) |
|
|
| -SLE | 21 (19.3) |
|
|
| -MCTD | 11 (10.1) |
|
|
| -Ankylosing spondylitis | 11 (10.1) |
|
|
| -Undifferentiated arthritis | 4 (3.7) |
|
|
| -Adult onset Still’s disease | 4 (3.7) |
|
|
| -Systemic sclerosis | 2 (1.8) |
|
|
| -Goujerot-Sjögren’s syndrome | 2 (1.8) |
|
|
| -Reactive arthritis | 1 (0.9) |
|
|
| -Polymyositis | 1 (0.9) |
|
|
| -Crohn’s disease | 1 (0.9) |
|
|
| -Psoriatic arthritis | 1 (0.9) |
|
|
| Comorbidities, N (%) | 96 (88) | N/A |
|
| -Infections | 73 (67) |
|
|
| -PUD | 56 (51.4) |
|
|
| -Osteoarthritis | 26 (23.8) |
|
|
| -Cancer | 3 (2.7) |
|
|
| -Asthma | 1 (0.9) |
|
|
| -Depression | 1 (0.9) |
|
|
| - Parkinson’s disease | 1 (0.9) |
|
|
| RA treatment, N (%) |
| NA |
|
| -Symptomatic treatment |
|
|
|
| Prednisone | 53 (48.6) |
|
|
| NSAIDS | 12 (11) |
|
|
| -Specific treatment |
|
|
|
| MTX | 38 (34.9) |
|
|
| HCQ | 31 (28.4) |
|
|
| SSZ | 8 (18.6) |
|
|
| AZT | 7 (10.1) |
|
|
| LEF | 1 (1.4) |
|
|
| -Without treatment | 28 (27.5) |
|
|